Michael K. Gibson
Beth Israel Deaconess Medical Center(US)Harvard University(US)Breast Cancer Research Foundation(US)Vanderbilt University(US)Baim Institute for Clinical Research(US)Tennessee Oncology(US)Vanderbilt-Ingram Cancer CenterVanderbilt University Medical Center(US)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Oesophageal carcinoma(2013)2,414 cited
- → Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,640 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology(2019)1,084 cited
- → Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology(2016)947 cited
- → Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study(2017)643 cited
- → Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group(2005)491 cited